The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHemogenyx Share News (HEMO)

Share Price Information for Hemogenyx (HEMO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.55
Bid: 1.53
Ask: 1.60
Change: 0.00 (0.00%)
Spread: 0.07 (4.575%)
Open: 1.60
High: 1.60
Low: 1.536
Prev. Close: 1.565
HEMO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Asimilar and Worldsec swing to profit

Fri, 30th Apr 2021 16:32

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Asimilar Group PLC - investment firm focused on big data, machine learning, telematics and the internet of things - For the six months ended March 31, swings to pretax profit of GBP23.4 million from loss of GBP565,583 the year before, through a gain of GBP21.8 million following the remeasurement of assets to fair value. Revenue remained unchanged year-on-year at GBP7,000. For the year ended September 30, 2020, company swings to pretax profit of GBP392,329 from loss of GBP731,784, while revenue remains flat at GBP14,000.

----------

Worldsec Ltd - South East Asia-focused investment company - For 2020, swings to pretax profit of USD944,000 from loss of USD704,000 the year before, due to a positive change in the fair value of the group's holdings in Homaer Class D shares driven by an increased value of the investment in Bytedance. Revenue however declined 31% year-on-year to USD96,000 from USD140,000, due to a lack of interest income.

----------

UP Global Sourcing Holdings PLC - Oldham, Greater Manchester-based consumer brands owner trading as Ultimate Products - For the six months ended January 31, pretax profit up 19% at GBP7.2 million from GBP6.0 million the year before, on revenue which grew 11% year-on-year to GBP75.4 million from GBP67.7 million, due to strong performances from Supermarkets and the group's online business. Declares interim dividend of 1.69 pence per share, up 46% from 1.16p the prior year. Looking ahead, expects annual underlying pretax profit in excess of GBP10.8 million, and revenue to be in excess of GBP135 million, up from GBP115.7 million the prior year.

----------

FireAngel Safety Technology Group PLC - Coventry-based home safety products maker - For 2020, pretax loss narrows at GBP9.3 million from GBP11.0 million the year before, in spite of 12% decline in revenue to GBP39.9 million from GBP45.5 million, driven by a fall in sales due to the effect of Covid-19 lockdowns on customer demand. Looking ahead, targets improved performance for 2021 following a good start to the year. FireAngel is looking to raise GBP9.8 million through a placing of 51.4 million shares at 18p each and GBP6.9 million via an open offer on the basis of 10 new shares for every 33 existing shares held. Proceeds will go towards funding research and development to accelerate new products. Appoints Zoe Fox, finance director of subsidiary FireAngel Safety Technology Ltd has been appointed group chief financial officer, replacing Jon Kempster.

----------

Blackstone Loan Financing Ltd - floating rate senior secured loans and bonds investment fund - As at December 31, net asset value per share up at EUR0.8557 from EUR0.8543 the same date the year before. Share price at the end of 2020 was EUR0.67 reflecting a 22% discount to net asset value. Declares dividend of EUR0.07 per share, down from EUR0.10 the prior year.

----------

Keystone Positive Change Investment Trust PLC - invests in UK stocks - For six months ended March 30, net asset value total return is minus 0.9%, compared to a positive 14.2% total return from the comparative index, comprising the FTSE All-Share index up to February 10 and the MSCI All Country World Index afterwards. Net asset value per share as at March 31 at 297.39 pence, down from 305.80p at the end of September 2020.

----------

Westminster Group PLC - Banbury-based security services provider - For 2020, pretax loss narrows to GBP761,000 from GBP1.3 million due to a drop in administrative expenses, despite a dip in revenue to GBP9.9 million from GBP10.9 million, due to a considerable decline in Managed Services. Looking ahead, outlook for 2021 is positive following a strong start. Expects pretax profit and revenue for 2021 to meet market expectations.

----------

AIQ Ltd - Cayman Islands-based firm focused on acquiring and developing e-commerce sector businesses - For year ended October 31, net loss widens to GBP3.6 million from GBP500,000 the year before, following the writing off of the investment in Alchemist Codes Sdn Bhd, which was acquired in March 2020. However, generates revenue of GBP154,649 from none the prior year, due to the sale of software products and maintenance income. Looking ahead, will focus on completing strategic review to assess the viability of Alchemist Codes.

----------

Tekcapital PLC - UK intellectual property investment company - As at November 30, net assets rise 45% year-on-year to USD32.7 million from USD22.5 million the same date the year before, as the value of the group's portfolio rises to USD30.5 million from USD20.3 million. For the year, pretax profit rises to GBP7.7 million from USD7.7 million from USD5.5 million, driven by revenue growth to USD9.9 million from USD7.7 million.

----------

Minoan Group PLC - developer of a holiday resort in Greece - For year ended October 31, pretax loss narrows to GBP876,000 from GBP2.1 million, due to the cancellation of warrants, leading to a credit rather than a charge for share-based payments. Looking ahead, has continued to prepare and progress the project in Crete, refinancing its indebtedness during the period.

----------

Greencare Capital PLC - cannabis sector-focused investment firm - for the 13 months ended October 31, posts pretax loss of GBP427,000. During period, makes two investments into Clearly Supplements Ltd and Voyager Life Ltd. Looking ahead, expects significant growth from the CBD sector in the short term.

----------

Honeycomb Investment Trust PLC - London-based investor in credit assets originated by non-bank lending platforms - As at December 31, net asset value per share dips to 1,013 pence from 1,015p the same date the year before, while net assets dropped to GBP357.2 million from GBP400.4 million. Declares dividend of 80.0p per share, in line with the year before.

----------

Scotgold Resources Ltd - gold exploration and production company focused on Scotland - For the six months ended December 31, pretax loss widens to AUD2.4 million from AUD1.3 million the year before, due to lower interest income and a lack of grants received in the prior year. Looking ahead, expects output from Cononish project for calendar year 2021 to be less than company's guidance range, as ramp up of underground mining production is set to be slower than originally planned.

----------

Midatech Pharma PLC - Cardiff-based drug delivery technology company - For 2020, pretax loss widens to GBP23.5 million from GBP10.9 million the year before, following a GBP12.4 million impairment charge after terminating the development of MTD201 and goodwill arising from the acquisition of Q Chip Ltd in 2014. Revenue meanwhile declined 49% year-on-year to GBP343,000 from GBP674,000.

----------

Iconic Labs PLC - London-based media and technology business - For the six months ended December 31, pretax loss widens to GBP934,707 from GBP762,130 a year prior due to rising consulting, legal and professional costs, more than offsetting sharp growth in revenue to GBP496,052 from GBP2,500 through the supply of management services to business partners.

----------

Hemogenyx Pharmaceuticals PLC - London-based biotechnology company - For 2020, pretax loss widens to GBP2.1 million from GBP1.5 million the year before, due to higher administrative costs, particularly in legal feels and laboratory expenses. Generates no revenue, in line with the prior year.

----------

Wildcat Petroleum PLC - seeking investment opportunities in upstream petroleum - For period from January 8 to Dec 31, posts maiden pretax loss of GBP67,000, due to administrative and listing costs. Looking ahead, reports progress in sourcing a potential oil asset.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 Sep 2023 19:43

IN BRIEF: Hemogenyx Pharmaceuticals says patent number published

Hemogenyx Pharmaceuticals PLC - London-based biopharmaceutical group developing new therapies and treatments for blood diseases - Says its patent application number "WO2023168292 Chimeric Bait Receptors and Uses Thereof" was published by the World Intellectual Property Organization on Thursday. Says it remains to be reviewed and approved by national patent authorities.

Read more
10 Jul 2023 10:27

Hemogenyx says Hemo-Car-T treatment placed on clinical hold by US FDA

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has received a review letter from the US Food & Drug Administration confirming its placement of Hemo-Car-T on clinical hold.

Read more
23 Jun 2023 15:51

UK shareholder meetings calendar - next 7 days

Monday 26 June 
Aterian PLCAGM
Capricorn Energy PLCAGM
Corre Energy BVAGM
Facilities by ADF PLCAGM
Lexington Gold LtdSGM re proposed acquisition of White Rivers Exploration Ltd
LifeSafe Holdings PLCAGM
Premier African Minerals LtdAGM
Vast Resources PLCGM re issuing new share capital
Volvere PLCAGM
Tuesday 27 June 
Acuity RM Group PLCAGM
Comptoir Group PLCAGM
Creo Medical Group PLCAGM
First Tin PLCAGM
Forward Partners Group PLCAGM
Galantas Gold CorpAGM
Gemfields Group LtdAGM
Golden Prospect Precious Metals LtdAGM
Hamak Gold LtdAGM
ICG Enterprise Trust PLCAGM
Impellam Group PLCAGM
India Capital Growth Fund LtdAGM
Inspiration Healthcare Group PLCAGM
Instem PLCAGM
JD Sports Fashion PLCAGM
Kingfisher PLCAGM
Mercantile Ports & Logistics LtdGM re equity fundraising
Mobile Tornado Group PLCAGM
Revolution Beauty Group PLCAGM
Scottish Mortgage Investment Trust PLCAGM
Serabi Gold PLCAGM
Sondrel Holdings PLCAGM
Surface Transforms PLCAGM
Surgical Innovations Group PLCAGM
Trinity Exploration & Production PLCAGM
Wednesday 28 June 
Atalaya Mining PLCAGM
Avacta Group PLCAGM
Boku IncAGM
Cambridge Cognition Holdings PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Cobra Resources PLCAGM
Cora Gold LtdAGM
Dial Square Investments PLCAGM
Itaconix PLCAGM
NB Distressed Debt Investment Fund LtdAGM
Panthera Resources PLCGM re directors’ authority to allot shares
Phoenix Spree Deutschland LtdAGM
Pineapple Power Corp PLCAGM
Polarean Imaging PLCAGM
RA International Group PLCAGM
Schroder European Real Estate Investment Trust PLCAGM
Shield Therapeutics PLCAGM
St Mark Homes PLCAGM
Star Phoenix Group LtdAGM
ValiRx PLCAGM
Velocys PLCAGM
Vertu Motors PLCAGM
Warpaint London PLCAGM
Westminster Group PLCAGM
Zenova Group PLCAGM
Thursday 29 June 
3i Group PLCAGM
Africa Opportunity Fund LtdAGM
Anemoi International LtdAGM
Anpario PLCAGM
Ariana Resources PLCAGM
Beowulf Mining PLCAGM
Celadon Pharmaceuticals PLCAGM
Cornish Metals IncAGM
East Imperial PLCAGM
East Star Resources PLCAGM
Eden Research PLCAGM
Engage XR Holdings PLCAGM
First Class Metals PLCAGM
Gresham House Energy Storage Fund PLCGM re remuneration policy
Gusbourne PLCAGM
HeiQ PLCAGM
Helios Underwriting PLCAGM
Ingenta PLCAGM
IQE PLCAGM
Kooth PLCAGM
Landore Resources LtdAGM
Let's Explore Group PLCAGM
Likewise Group PLCAGM
MGC Pharmaceuticals LtdGM re issue of convertible notes
Morgan Advanced Materials PLCAGM
NetScientific PLCAGM
New Century AIM VCT 2AGM
Norman Broadbent PLCAGM
Reabold Resources PLCAGM
Rockhopper Exploration PLCAGM
Roquefort Therapeutics PLCAGM
Serica Energy PLCAGM
SpaceandPeople PLCAGM
Symphony Environmental Technologies PLCAGM
Synairgen PLCAGM
Thalassa Holdings LtdAGM
tinyBuild IncAGM
Touchstone Exploration IncAGM
Trident Royalties PLCAGM
Unigel Group PLCAGM
Verici Dx PLCAGM
Xpediator PLCAGM
Friday 30 June 
Argo Blockchain PLCAGM
Ascent Resources PLCAGM
Bluejay Mining PLCAGM
Caspian Sunrise PLCAGM
Codex Acquisitions PLCAGM
Domino's Pizza Group PLCGM re directors' remuneration policy
Fenikso LtdAGM
Fiinu PLCAGM
FireAngel Safety Technology Group PLCAGM
GENinCode PLCAGM
Hemogenyx Pharmaceuticals PLCAGM
Hiro Metaverse Acquisitions I SAAGM
i3 Energy PLCGM re premium share cancellation
ImmuPharma PLCAGM
Inspired PLCAGM
Jadestone Energy PLCAGM
Kanabo Group PLCAGM
Kefi Gold & Copper PLCAGM
Kistos Holdings PLCAGM
KRM22 PLCAGM
Kropz PLCAGM
LoopUp Group PLCAGM
Medica Group PLCAGM
Mirriad Advertising PLCAGM
Rockfire Resources PLCAGM
Savannah Energy PLCAGM
Strip Tinning Holdings PLCAGM
ThomasLloyd Energy Impact Trust PLCAGM
URA Holdings PLCAGM
World Chess PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
2 Jun 2023 13:08

IN BRIEF: Hemogenyx announces clinical hold for Hemo-Car-T treatment

Hemogenyx Pharmaceuticals PLC -hemo London-based biopharmaceutical group developing new therapies and treatments for deadly blood diseases - Notes receipt of notice from the US Food & Drug Administration over its investigational new drug application for its product candidate Chimeric Antigen Receptor T-cells, or Hemo-Car-T. Says Hemo-Car-T is a treatment for acute myeloid leukemia. Says FDA put Hemo-Car-T on clinical hold, pending an FDA letter to be received within 30 days detailing what additional information needs to be provided by Hemogenyx. Hemogenyx submitted the investigational new drug application in early May, seeking authorisation to begin a phase 1 clinical trial of Hemo-Car-T.

Read more
9 May 2023 15:16

IN BRIEF: Hemogenyx submits FDA application for Hemo-Car-T treatment

Hemogenyx Pharmaceuticals PLC - London-based biopharmaceutical group developing new therapies and treatments for deadly blood diseases - Submits investigational new drug application seeking authorisation from the US Food & Drug Administration to begin a phase 1 clinical trial of its lead product chemic antigen receptor T-cells, or Hemo-Car-T, for treating acute myeloid leukemia.

Read more
28 Apr 2023 15:35

EARNINGS SUMMARY: DP Aircraft profit swing, Chesterfield loss widens

(Alliance News) - The following is a round-up of earnings updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
23 Mar 2023 20:32

TRADING UPDATES: Fragrant Prosperity to buy Hi 55, Oscillate talks end

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday not separately reported by Alliance News:

Read more
26 Jan 2023 10:45

Hemogenyx raises GBP4 million in share placing for Hemo-CAR-T product

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Thursday said it successfully raised GBP4.1 million in a placing of new shares, with the fresh cash to be used to progress its Hemo-CAR-T product candidate into clinical trials.

Read more
23 Jan 2023 16:59

IN BRIEF: Hemogenyx completes process run for HEMO-CAR-T manufacture

Hemogenyx Pharmaceuticals PLC - London-based biopharmaceutical group developing new therapies and treatments for deadly blood diseases - Completes third process qualification run for the manufacture of HEMO-CAR-T cells. Says the HEMO-CAR-T cells will be tested by third party to ensure quality. The three process runs are required by the US Food & Drug Administration to begin clinical trials. Following completion of all tests across all PQ runs, data will be compiled for inclusion in the investigational new drug submission pack. HEMO-CAR-T cells are being developed the potential treatment of acute myeloid leukemia, a blood and bone marrow cancer.

Read more
9 Jan 2023 10:21

Hemogenyx shares up on single target protein virus treatment finding

(Alliance News) - Hemogenyx Pharmaceuticals PLC shares jumped early Monday, after the company announced the discovery of a single target protein for use against multiple dangerous viruses.

Read more
4 Jan 2023 11:12

IN BRIEF: Hemogenyx Pharma second process qualification run successful

Hemogenyx Pharmaceuticals PLC - London-based biotechnology company - Successfully completes its second process qualification run of the end-to-end process for the manufacture of HEMO-CAR-T cells. The company says it was followed by analytical release tests to verify the quality of the manufactured cells. The run is the second of three identical manufacturing runs required by the US Food and Drug Administration for the submission of an investigational new drug application. The IND application is needed in order to commence phase one clinical trials of HEMO-CAR-T cells.

Read more
4 Jan 2023 10:36

SMALL-CAP WINNERS & LOSERS: HeiQ drops on expectation of lower sales

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Wednesday.

Read more
18 Nov 2022 16:21

Hemogenyx makes final development run of HEMO-CAR-T cell manufacture

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Friday said it has completed the final development run for its manufacturing process of HEMO-CAR-T cells.

Read more
29 Sep 2022 15:09

EARNINGS UPDATES: Hemogenyx hopes on cancer drug; IDE loss widens

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
15 Aug 2022 09:50

Hemogenyx wins patent for bi-specific antibody method in China

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has been awarded a patent for its bi-specific antibody in China.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.